These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 13423469)

  • 1. [In vitro bacteriological testing of some new N1-acylated sulfanilamides].
    SEMENITZ E
    Z Immun exp ther; 1957 Feb; 113(6):486-8. PubMed ID: 13423469
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
    Bhattacharya G; Herman J; Delfín D; Salem MM; Barszcz T; Mollet M; Riccio G; Brun R; Werbovetz KA
    J Med Chem; 2004 Mar; 47(7):1823-32. PubMed ID: 15027874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental research on absorption and hypoglycemic action of N1-sulfanilyl-N2-n-butyl urea and N-4-methyl-benzene sulfonyl-N1-butyl urea, rectal administration].
    GIANNI AM
    Boll Soc Ital Biol Sper; 1956; 32(10-11):1289-91. PubMed ID: 13426314
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isolation and identification of N1-acetyl-p-aminophenylsulfamide in the urine of sulfanilamide-treated rats].
    MILHAUD G; AUBERT JP; BOYER F
    C R Hebd Seances Acad Sci; 1955 May; 240(21):2090-1. PubMed ID: 14390796
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre-systemic metabolism prevents in vivo antikinetoplastid activity of N1,N4-substituted 3,5-dinitro sulfanilamide, GB-II-150.
    Wu D; George TG; Hurh E; Werbovetz KA; Dalton JT
    Life Sci; 2006 Aug; 79(11):1081-93. PubMed ID: 16643960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N1-sulfanyl N2-n-butylcarbamide (BZ 55) in the treatment of diabetes mellitus].
    TRAVERSO R; PATELLI R
    Friuli Med; 1956; 11(6, bis):1053-60. PubMed ID: 13438118
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the total & renal clearance of N1-sulfanilyl-N2-n-butyl-carbamide (nadisan)].
    KLAUS D; STRIPECKE W
    Z Gesamte Inn Med; 1957 Apr; 12(7):289-94. PubMed ID: 13456727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of simple and acetylated N1-sulfanilyl-N2-n-butylcarbamide on aerobic glycolysis of liver tissue].
    SALGARELLO G
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1463-5. PubMed ID: 13446093
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of methoxy-substituted N1-benzenesulfonylindole analogs at human 5-HT6 serotonin receptors.
    Siripurapu U; Kolanos R; Dukat M; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3793-6. PubMed ID: 16709453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites.
    Werbovetz KA; Sackett DL; Delfín D; Bhattacharya G; Salem M; Obrzut T; Rattendi D; Bacchi C
    Mol Pharmacol; 2003 Dec; 64(6):1325-33. PubMed ID: 14645662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro inhibition of sulfanilamide acetylation by aletheine].
    GARATTINI S; MORPURGO C; PASSERINI N
    G Ital Chemioter; 1954; 1(3-4):584-7. PubMed ID: 14391677
    [No Abstract]   [Full Text] [Related]  

  • 12. Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline sulfonamides and benzamides.
    George TG; Johnsamuel J; Delfín DA; Yakovich A; Mukherjee M; Phelps MA; Dalton JT; Sackett DL; Kaiser M; Brun R; Werbovetz KA
    Bioorg Med Chem; 2006 Aug; 14(16):5699-710. PubMed ID: 16675220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New sulfonamides and delayed action sulfonamides].
    RENTCHNICK P
    Schweiz Med Wochenschr; 1958 Apr; 88(15):362-8. PubMed ID: 13555740
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new diagnostic reaction that is specific for myeloma].
    MANZINI C; TURCHETTO E
    Bull Sci Med (Bologna); 1958; 130(2):205-9. PubMed ID: 13573176
    [No Abstract]   [Full Text] [Related]  

  • 15. [New peroral treatment of diabetes].
    HUNSKI M
    Lijec Vjesn; 1956; 78(11-12):499-505. PubMed ID: 13450439
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological research on two new antidiabetic drugs].
    SIMON I
    Boll Soc Ital Biol Sper; 1956; 32(10-11):1329-31. PubMed ID: 13426327
    [No Abstract]   [Full Text] [Related]  

  • 17. [New methods of treating trachoma with etazol and rhonidase].
    DIUDINA ZT
    Vestn Oftalmol; 1957; 70(6):32-6. PubMed ID: 13530571
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with a new oral hypoglycaemic drug.
    MUKHERJEE SK; DE UN; MUKERJI B
    J Indian Med Assoc; 1957 Jun; 28(11):466-8. PubMed ID: 13449331
    [No Abstract]   [Full Text] [Related]  

  • 19. [First experiences with the new oral antidiabetic invenol].
    FIALA E; BALASSA M
    Orv Hetil; 1957 May; 98(21):554-5. PubMed ID: 13452526
    [No Abstract]   [Full Text] [Related]  

  • 20. [New anti-diabetic sulfonamides: personal results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(2):147-9. PubMed ID: 13454211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.